Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Recruiting 1

Sponsor Class

NIH 1

Study Type

Interventional 1

Sponsor

Cancer Type

Other hematologic neoplasm 1

Conditions

Leukemia, Myeloid, Acute 124Leukemia, Lymphocytic, Chronic, B-Cell 30Myelodysplastic Syndromes 27Leukemia 21Precursor Cell Lymphoblastic Leukemia-Lymphoma 18Recurrence 17Precursor T-Cell Lymphoblastic Leukemia-Lymphoma 10Lymphoma 9Leukemia, Biphenotypic, Acute 8Hematologic Neoplasms 8Leukemia, Myelomonocytic, Chronic 7Neoplasm, Residual 6Multiple Myeloma 6Lymphoma, Mantle-Cell 6Burkitt Lymphoma 6Neoplasms 5Waldenstrom Macroglobulinemia 4Precursor B-Cell Lymphoblastic Leukemia-Lymphoma 4Myeloproliferative Disorders 4Lymphoma, Non-Hodgkin 4Lymphoma, B-Cell, Marginal Zone 4Leukemia, Myeloid 4Leukemia, Monocytic, Acute 3GATA2 Deficiency 3Sarcoma, Myeloid 2Lymphoma, Large B-Cell, Diffuse 2Leukemia, Myelogenous, Chronic, BCR-ABL Positive 2Immunoglobulin Light-chain Amyloidosis 2Blastic Plasmacytoid Dendritic Cell Neoplasm 2Anemia, Refractory, with Excess of Blasts 2

Interventions

Rituximab 4Cladribine 3binimetinib 2Specimen Handling 2CT-P10 2Biopsy 2venetoclax 1tovorafenib 1polatuzumab vedotin 1obinutuzumab 1ibrutinib 1encorafenib 1Vemurafenib 1Spinal Puncture 1Prednisone 1Positron-Emission Tomography 1Magnetic Resonance Spectroscopy 1Lenalidomide 1Doxorubicin 1Cyclophosphamide 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Recruiting × Leukemia, Hairy Cell × venetoclax × Clear all
NCT06311227 2026-05-13

Venetoclax for the Treatment of Patients With Relapsed Hairy Cell Leukemia

National Cancer Institute (NCI)

Phase 2 Recruiting
20 enrolled
Other hematologic neoplasm

Leukemia, Hairy Cell

Data powered by HemOnc (CC BY 4.0) Colophon âš¡